Rytary ER 36.25 MG-145 MG cap 100S
Ended Awarded
- Contract number
- SPE2DB26FQ94R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,853
Award facts
- Contract value 100% obligated
- $16,853.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,853.24 to AmerisourceBergen Drug Corp for the supply of RYTARY ER 36.25 mg-145 mg capsules (100-count units) on November 10, 2025, with an ultimate completion date of November 12, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. RYTARY is a carbidopa-levodopa extended-release medication used in the treatment of Parkinson's disease, reflecting the pharmaceutical supply needs of military and veteran healthcare systems supported by DLA.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of delivery orders for brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's competitive award of this and related orders demonstrates its established capability to meet federal healthcare requirements through open procurement channels and supports DLA's mission to supply pharmaceuticals and medical commodities to military healthcare programs globally.
Quick answers
Who was awarded contract SPE2DB26FQ94R?
SPE2DB26FQ94R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FQ94R worth?
The government has obligated $16,853 on SPE2DB26FQ94R.
Is contract SPE2DB26FQ94R an order under another contract?
Yes. SPE2DB26FQ94R is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB26FQ94R competed?
The extent of competition for SPE2DB26FQ94R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award